Vancouver, British Columbia – December 15, 2020 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that it has signed an agreement with Luxembourg-based analytics and marketing specialist CURE Intelligence to manage online analytics and social media communication.
The agreement was signed December 8th and will continue for a period of 12 months.
“We realize the power of social media in bringing awareness of our technology to a greater audience both efficiently and with improved content. We have been working to increase our virtual presence and have now found a partner that can reach more potential partners and expand our business development,” said Dr. Howard Verrico, CEO of Sirona Biochem. “We look forward to this new relationship with the team at CURE. During our due diligence, we’ve been impressed with their commitment to hard work and their ability to add significant value to our communications.”
"Sirona Biochem is on the verge of a new chapter in the company's history. After years of research and development of its platform technology, the company is about to commercialize one of its compounds and achieve other significant milestones. We look forward to raising awareness of Sirona and its breakthrough technology among targeted audiences through regular effective content and data-driven distribution on social media" comments Marco Feiten, Managing Director at CURE Intelligence.
About CURE Intelligence
Founded in 2009, CURE specializes in the field of media monitoring and analysis, data intelligence, social media communications and content marketing. CURE helps its clients make better decisions and improve internal and external communication processes by effectively combining analytics and marketing.
CURE is a joint-stock company based in Grevenmacher, Luxembourg, and works with internationally renowned clients from Germany, Luxembourg, Canada and the U.S. For more information, please visit www.cure-intelligence.com.